September 2020

Compliance and Disclosure Interpretations

• Securities Act Forms (UPDATED 09/21/20)
  • Section 115. Form S-3 — General Instructions I.A.1 to I.A.8 — Registrant Requirements
    • Question 115.18
• Regulation S-K (UPDATED 09/21/20)
  • Section 219. Item 402(c) — Executive Compensation; Summary Compensation Table
    • Question 219.05

Disclosure Guidance Topics

• CF Disclosure Guidance Topic No. 7 updated to provide new guidance relating to options available to companies whose confidential treatment orders are about to expire, September 9, 2020

No-Action, Interpretive and Exemptive Letters

• Salt Blockchain Inc., September 30, 2020
  • See Commission Order, available at: https://www.sec.gov/rules/other/2020/33-10866.pdf
• Aegon N.V., September 30, 2020
  • See Commission Order, available at: https://www.sec.gov/rules/other/2020/33-10864.pdf
• Morgan Stanley & Co. LLC,, September 30, 2020
• Sentry Insurance a Mutual Company, September 22, 2020
• Northern Trust Corporation, September 18, 2020
  • See Commission Order, available at: https://www.sec.gov/rules/other/2020/33-10846.pdf
• FuelCell Energy, Inc., September 3, 2020